Two-week Triple Therapy has a Higher Helicobacter pylori Eradication Rate Than 1-week Therapy: A Single-center Randomized Study.

Background and Aim: To evaluate a high effective and practical regimen for the eradication of Helicobacter pylori infection. Patients and Methods: The 298 patients with H. pylori infection, diagnosed by biopsies performed during the endoscopy, were randomized into two groups. Group 1: Treated for on...

Descripción completa

Detalles Bibliográficos
Publicado en:Saudi Journal of Gastroenterology Vol. 21; no. 6; pp. 355 - 360
Autores principales: Jiaofeng Wang, Gansheng Zhang, Xiaona Hu, Ye Liu, Zhijun Bao, Yiqin Huang
Formato: research tables/charts randomized controlled trial Journal Article
Publicado: Wolters Kluwer India Pvt Ltd Nov/Dec2015
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=111491816&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 111491816
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        13193767
        322P
      jtl: Saudi Journal of Gastroenterology
      issn: 13193767
      maglogo: N
    pubinfo:
      dt: Nov/Dec2015
      vid: 21
      iid: 6
      pid: 16919
      pub: Wolters Kluwer India Pvt Ltd
    artinfo:
      ui:
        111491816
        111491816
        111491816
        10.4103/1319-3767.170951
        111491816
      ppf: 355
      ppct: 5
      formats:
      tig:
        atl: Two-week Triple Therapy has a Higher Helicobacter pylori Eradication Rate Than 1-week Therapy: A Single-center Randomized Study.
      aug:
        au:
          Jiaofeng Wang
          Gansheng Zhang
          Xiaona Hu
          Ye Liu
          Zhijun Bao
          Yiqin Huang
        affil: Department of Geriatrics, Huadong Hospital, Shanghai, China
      sug:
        subj:
          Helicobacter Infections Drug Therapy
          Omeprazole Therapeutic Use
          Amoxicillin Therapeutic Use
          Clarithromycin Therapeutic Use
          Randomized Controlled Trials
          Human
          Biopsy
          Endoscopy
          Omeprazole Administration and Dosage
          Amoxicillin Administration and Dosage
          Clarithromycin Administration and Dosage
          Breath Tests
          Treatment Outcomes
          Helicobacter Infections Diagnosis
          Drug Combinations
          Urease
      ab: Background and Aim: To evaluate a high effective and practical regimen for the eradication of Helicobacter pylori infection. Patients and Methods: The 298 patients with H. pylori infection, diagnosed by biopsies performed during the endoscopy, were randomized into two groups. Group 1: Treated for one week with a combination of omeprazole, amoxicillin, and clarithromycin (OAC), named by OAC-1 group (n Group= 143); Group 2: OAC-2 group (n = 155) treated for two weeks with OAC. The OAC=155)-1 group was treated with triple therapy of omeprazole 20 mg, amoxicillin 1000 mg, and clarithromycin 500 mg bid for 1 week. OAC-2 group was treated likewise, but for two weeks. A 13C-urea breath test was used to monitor H. pylori after four to eight weeks following therapy. Results: The eradication of infection was 55% and 68% in the OAC-1 and OAC-2 groups, respectively. Moreover, the eradication rates in the two groups were 63% and 75%, respectively. Compared with the OAC-1 group, the efficacy of treatment in the OAC-2 group is significantly higher (P < 0.05). Conclusion: Two-week OAC regimen yields a higher eradication rate of H. pylori, which might be a practical regimen for the eradication of H. pylori.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N